A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
- NCT ID
- NCT02715115
- Sponsor
- Neuren Pharmaceuticals Limited
- Registry dates
- 2016-03 – 2017-01-05
- Enrollment
- 82 registered participants
- Locations
- United States
- Conditions listed
- Rett Syndrome
This page lists ClinicalTrials.gov records that name Ipamorelin among their listed interventions. Titles, phases, and status are taken from the official registry. It is a research reference only. It is not medical advice, and it does not offer or recommend any product for human or veterinary use.
View Ipamorelin in the catalog
No registered studies match that search or filter.
Ask us about orders, shipping or products.

Cloud 9 Research supplies research peptides to qualified researchers and laboratories for in vitro and laboratory use only. Please confirm before continuing.
Please check the email address, or leave it blank to continue.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.
Not a researcher? Exit